Guided Therapeutics Inc financial data

Symbol
GTHP on OTC
Location
5835 Peachtree Corners East, Suite B, Peachtree Corners, GA
State of incorporation
DE
Fiscal year end
December 31
Former names
SPECTRX INC (to 2/28/2008)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 25.3 % -56.8%
Quick Ratio 12.3 % +1.07%
Debt-to-equity -207 % -72.1%
Return On Equity 66.3 %
Return On Assets -138 % +19.2%
Operating Margin -5.59K % +14.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.6M shares +10.3%
Common Stock, Shares, Outstanding 54.1K shares
Entity Public Float 11.5M USD +61.6%
Common Stock, Value, Issued 3.44M USD +0.12%
Weighted Average Number of Shares Outstanding, Diluted 56K shares +9.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 38K USD -44.9%
Research and Development Expense 431K USD +259%
Selling and Marketing Expense 276K USD +16%
General and Administrative Expense 1.43M USD -65.2%
Operating Income (Loss) -2.12M USD +53%
Nonoperating Income (Expense) -51K USD -3.85%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -709K USD +54.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.17M USD +59.2%
Earnings Per Share, Basic -0.04 USD/shares +63.6%
Earnings Per Share, Diluted -0.04 USD/shares +63.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 731K USD -72.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2K USD -71.4%
Inventory, Net 632K USD +10.3%
Other Assets, Current 112K USD +23.1%
Assets, Current 1.02M USD -49.7%
Property, Plant and Equipment, Net 28K USD -22.2%
Operating Lease, Right-of-Use Asset 185K USD -30.5%
Other Assets, Noncurrent 17K USD 0%
Assets 1.25M USD -46.7%
Accounts Payable, Current 2.14M USD +0.71%
Accrued Liabilities, Current 840K USD -13.5%
Liabilities, Current 5.73M USD +16.1%
Operating Lease, Liability, Noncurrent 104K USD -48.5%
Liabilities 5.92M USD +4.5%
Retained Earnings (Accumulated Deficit) -152M USD -1.59%
Stockholders' Equity Attributable to Parent -4.67M USD -40.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.65M USD +47.8%
Liabilities and Equity 1.25M USD -46.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -100K USD +80%
Net Cash Provided by (Used in) Financing Activities -46K USD -300%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 56.3K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 275K USD -79.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -74.5%
Deferred Tax Assets, Valuation Allowance 17.9M USD +5.11%
Deferred Tax Assets, Gross 17.9M USD +5.11%
Operating Lease, Liability 203K USD -29.3%
Depreciation 2K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 226K USD -33.3%
Property, Plant and Equipment, Gross 1.61M USD -9.93%
Operating Lease, Liability, Current 99K USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50K USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 118K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23K USD -55.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50K USD -56.5%
Deferred Tax Assets, Operating Loss Carryforwards 16.4M USD -0.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 118K USD 0%
Additional Paid in Capital 141M USD +0.73%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 14.8K USD -86.1%
Interest Expense 282K USD -21.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%